Latest Financial Performance News

Steadfast Group Limited has posted a 17.2% rise in underlying net profit after tax for FY25, marking its 12th consecutive year of growth, even as its CEO steps aside pending an investigation. The company also announced a leadership transition with Vicki Allen named incoming Chair.

Enlitic, Inc. reported a strong quarter with record cash receipts and contract wins, yet withdrew its revenue guidance due to delayed project completions. The company remains confident in reaching operational cash flow break-even by the end of Q4 FY25.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

Platformo Ltd’s Biztrak software business experienced a 30% revenue decline in Q3 2025 due to deferred demand following changes to Malaysia’s e-invoicing compliance timeline. Despite this, the company maintained strong cash reserves and advanced key product enhancements.

Austral Gold’s Q3 report reveals a sharp production drop at Guanaco following a fatal accident, prompting a downward revision of 2025 output and cost hikes, while Casposo’s refurbishment signals a new growth phase.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.

Jupiter Mines reported a 5% increase in manganese production for Q1 FY2026, yet sales volumes and EBITDA declined, reflecting a complex market environment. Despite these shifts, the company maintains a strong cash position and steady manganese prices.

Hydralyte USA reported a 6% year-on-year sales increase in Q3 FY25 alongside a significant 42% reduction in operating cash burn, driven by a streamlined US-focused model and new product launches in brain and gut health.

CAR Group Limited has reported robust FY25 financial results with strong revenue and profit growth, underpinned by strategic investments in AI and digital marketplaces. The company projects continued momentum into FY26, aiming to deepen market leadership across global regions.

IMEXHS Limited reported a 9% rise in Q3 FY25 revenue and a positive swing to $0.6m underlying EBITDA, reaffirming full-year guidance. Key contract wins and AI-driven efficiencies underpin margin gains despite political uncertainties in Colombia.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Cluey Ltd reported a stable Q1 FY26 revenue of $7.4 million alongside its strongest-ever underlying EBITDA, as it accelerates investment in AI-driven educational products set to launch in 2026.